BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35900839)

  • 21. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
    Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
    J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group.
    van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
    Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
    Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
    Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
    Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.
    Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
    Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
    Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
    Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
    Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
    Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
    Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
    Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
    Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1.
    van den Broek MFM; van Nesselrooij BPM; Pieterman CRC; Verrijn Stuart AA; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Havekes B; Kerstens MN; Bisschop PH; Valk GD
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32396602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
    Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
    Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas.
    Luzi E; Ciuffi S; Marini F; Mavilia C; Galli G; Brandi ML
    Am J Transl Res; 2017; 9(4):1743-1753. PubMed ID: 28469779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
    Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of an intracellular stability test of a novel missense menin mutant to the diagnosis of multiple endocrine neoplasia type 1.
    Nagamura Y; Yamazaki M; Shimazu S; Tsukada T; Sakurai A
    Endocr J; 2012; 59(12):1093-8. PubMed ID: 22878668
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.